Registration - Amendment

WINNING STRATEGIES WASHINGTON for MEDA PHARMACEUTICALS

Period 1st Quarter 2011 Filed Feb 23, 2011 Signed by Donna F. Mullins, Managing Partner

Official filing
Firm
WINNING STRATEGIES WASHINGTON
Client
MEDA PHARMACEUTICALS
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA Risk Evaluation and Mitigation Strategies

LobbyistCovered position, as disclosed
ALEX DELPIZZO New LD/LA Rep. Ferguson; Transportation and Infrastructure Cmte
MICHAEL A MEROLA New Deputy CoS, Sen. Torricelli

Pharmacy PHA

FDA Risk Evaluation and Mitigation Strategies

LobbyistCovered position, as disclosed
ALEX DELPIZZO New LD/LA Rep. Ferguson; Transportation and Infrastructure Cmte
MICHAEL A MEROLA New Deputy CoS, Sen. Torricelli

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.